Literature DB >> 10683207

Agonist binding to G-protein coupled receptors.

P G Strange1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10683207      PMCID： PMC1571878          DOI： 10.1038/sj.bjp.0702991

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  16 in total

Review 1.  Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

Authors:  D Colquhoun
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

2.  An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium.

Authors:  D A Horstman; S Brandon; A L Wilson; C A Guyer; E J Cragoe; L E Limbird
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

3.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

Review 4.  The energetics of ligand binding at catecholamine receptors.

Authors:  P G Strange
Journal:  Trends Pharmacol Sci       Date:  1996-07       Impact factor: 14.819

5.  Three-state and two-state models.

Authors:  P G Strange
Journal:  Trends Pharmacol Sci       Date:  1998-03       Impact factor: 14.819

6.  Identification of residues required for ligand binding to the beta-adrenergic receptor.

Authors:  C D Strader; I S Sigal; R B Register; M R Candelore; E Rands; R A Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.

Authors:  C D Wang; M A Buck; C M Fraser
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

Review 8.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

Authors:  R J Lefkowitz; S Cotecchia; P Samama; T Costa
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

9.  Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.

Authors:  C D Wang; T K Gallaher; J C Shih
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

10.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.

Authors:  C D Strader; I S Sigal; M R Candelore; E Rands; W S Hill; R A Dixon
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157
View more
  4 in total

Review 1.  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

2.  Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT(1A) receptors.

Authors:  Shuiyu Lu; Jeih-San Liow; Sami S Zoghbi; Jinsoo Hong; Robert B Innis; Victor W Pike
Journal:  Curr Radiopharm       Date:  2010-01

3.  Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Authors:  Jun-Xu Li; Alison Unzeitig; Martin A Javors; Kenner C Rice; Wouter Koek; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-08-17       Impact factor: 4.030

4.  Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacy.

Authors:  Kirstie A Bennett; Benjamin Tehan; Guillaume Lebon; Christopher G Tate; Malcolm Weir; Fiona H Marshall; Christopher J Langmead
Journal:  Mol Pharmacol       Date:  2013-02-19       Impact factor: 4.436
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.